Icecure Medical is trading 6.92% up at $2.78 in after-hours trading, with no fresh announcement explaining the rebound.

  • It closed at $2.60 on August 18, 2026, after two consecutive declines.
  • Its August 12 earnings release reported first-half revenue growth of 45%, alongside an $8.8 million net loss and continued pressure from weaker-than-expected quarterly results.
  • The rebound came during a risk-off session: Nasdaq fell 1.56% and S&P 500 fell 0.69%.